Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) Equity Average (2016 - 2025)

Historic Equity Average for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $5.6 million.

  • Jaguar Health's Equity Average fell 6212.64% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year decrease of 6212.64%. This contributed to the annual value of $5.7 million for FY2024, which is 22168.88% up from last year.
  • Jaguar Health's Equity Average amounted to $5.6 million in Q3 2025, which was down 6212.64% from $3.9 million recorded in Q2 2025.
  • Jaguar Health's 5-year Equity Average high stood at $31.8 million for Q2 2021, and its period low was $1.1 million during Q4 2022.
  • Over the past 5 years, Jaguar Health's median Equity Average value was $6.7 million (recorded in 2023), while the average stood at $10.3 million.
  • Its Equity Average has fluctuated over the past 5 years, first skyrocketed by 71877.33% in 2021, then tumbled by 9328.54% in 2022.
  • Over the past 5 years, Jaguar Health's Equity Average (Quarter) stood at $16.7 million in 2021, then tumbled by 93.29% to $1.1 million in 2022, then soared by 181.45% to $3.2 million in 2023, then soared by 210.33% to $9.8 million in 2024, then tumbled by 42.63% to $5.6 million in 2025.
  • Its Equity Average stands at $5.6 million for Q3 2025, versus $3.9 million for Q2 2025 and $3.7 million for Q1 2025.